Patents on a series of blockbuster drugs are due to expire between now and 2030. Last time this happened it sparked a wave of industry consolidation – but today, Allen & Overy expects a different type of deal-making.
Read the full article: USD200B Patent Cliff Set to Spark New Wave of Life Sciences M&A – But It Might Not Look Like the Last One //
Source: https://www.allenovery.com/en-gb/global/news-and-insights/publications/usd200bn-patent-cliff-set-to-spark-new-wave-of-life-sciences-ma-but-it-might-not-look-like-the-last-one